Cardura XL recall: Impurity Out of Spec
Cardura XL (doxazosin) extended release tablets 4mg, 30-count bottles, Rx Only, Made in Singapore, Distributed by Roerig Division of Pfizer Inc, NY, NY 10017 NDC 0049-2040-10
Why was Cardura XL recalled?
Failed Impurities/Degradation Specifications
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: 8147040; Exp. June 2024 Lot #: 8163764; Exp. March 2025
- Product
- Cardura XL (doxazosin) extended release tablets 4mg, 30-count bottles, Rx Only, Made in Singapore, Distributed by Roerig Division of Pfizer Inc, NY, NY 10017 NDC 0049-2040-10
- Recalling firm
- Viatris Inc
- Quantity
- 12,691 bottles
- Distribution
- U.S. Nationwide
- Recall date
- July 24, 2024
- Classification
- Class II
- Status
- Completed
- Agency
- FDA (drug)